Comments
Lincoln Pharmaceuticals Ltd has reported an increase of 4 per cent in revenue and 94 per cent in net profit in the third quarter of 2013-14 ended December 31, 2013, as compared to the corresponding quarter in the last fiscal.
While the company’s standalone revenue was Rs 51.98 crore (Rs 49.68 crore) and profit-after-tax (PAT) stood at Rs 3.83 crore (Rs 1.97 crore), according to a press release here.
The company increased profitability despite the pressure of inflation, increase in input cost and financial cost in general economic situation in the country.
Lincoln Pharma is considering new capital investments in the R&D unit and proposes to set up a USFDA rules compliant plant to cater to domestic as well as regulated markets.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.